Free Trial
LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 684 0.00 (0.00%)
As of 08/28/2025 12:05 PM Eastern

About International Biotechnology Stock (LON:IBT)

Key Stats

Today's Range
680
688
50-Day Range
584
684
52-Week Range
480
736
Volume
116,079 shs
Average Volume
90,866 shs
Market Capitalization
£245.70 million
P/E Ratio
6.53
Dividend Yield
4.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IBT Stock News Headlines

BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
UK firms fear tougher employment regulation, CBI says
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 682 on January 1st, 2025. Since then, IBT shares have increased by 0.3% and is now trading at GBX 684.

International Biotechnology (LON:IBT) announced its quarterly earnings data on Tuesday, May, 13th. The company reported ($5.60) earnings per share for the quarter. International Biotechnology had a net margin of 90.66% and a trailing twelve-month return on equity of 13.67%.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP).

Company Calendar

Last Earnings
5/13/2025
Today
8/28/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 104.80
Trailing P/E Ratio
6.53
Forward P/E Ratio
724.89
P/E Growth
N/A
Net Income
£37.91 million
Net Margins
90.66%
Pretax Margin
N/A
Return on Equity
13.67%
Return on Assets
3.57%

Debt

Debt-to-Equity Ratio
8.09
Current Ratio
N/A
Quick Ratio
0.32

Sales & Book Value

Annual Sales
£41.82 million
Price / Sales
5.88
Cash Flow
GBX 4.39 per share
Price / Cash Flow
155.74
Book Value
GBX 766.24 per share
Price / Book
0.89

Miscellaneous

Outstanding Shares
35,921,299
Free Float
N/A
Market Cap
£245.70 million
Optionable
Not Optionable
Beta
0.21
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (LON:IBT) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners